Back to Search
Start Over
Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review.
- Source :
- Clinical Case Reports; Oct2021, Vol. 9 Issue 10, p1-6, 6p
- Publication Year :
- 2021
-
Abstract
- Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor-kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 9
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- 153446024
- Full Text :
- https://doi.org/10.1002/ccr3.4993